Answer
Palopegteriparatide is a prodrug linking PTH(1-34) to a methoxypolyethylene glycol carrier via a TransCon Linker, from which PTH is cleaved in a controlled manner under physiological conditions to provide continuous systemic exposure to active PTH.
Sources for this answer
- Yorvipath 294 micrograms/0.98 mL solution for injection in pre filled penAscendis Pharma UK Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 4Document updated
Sources checked